echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Official xuan slow disease long prescription issued, Jinan-based medicine 9.8.6 schedule landing.

    Official xuan slow disease long prescription issued, Jinan-based medicine 9.8.6 schedule landing.

    • Last Update: 2020-07-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Business owners --- sales force --- learning documents--- marketing department follow-up --- follow-up clinical / outpatient --- chain, first start strong, then drink soup.!----Slow-sick long prescriptions know that the document landing slow-sick long prescription has not been particularly clear guidance document, this published a clear executable guidance document, clear the maximum prescription time range, the following document for a brief chat(Source: Official Document) Document Main Content: Objective: To develop and improve long-term prescription management policies for chronically ill patients, to clarify the chronic prescription of the disease catalogue, the scope of medication, management system, safety notification requirements, etc., to reduce the number of patients taking medicinein short, everything for the sake of the patient, for the convenience of the patientthe scope of implementation: long-term drug use (including narcotic drugs, psychotropic drugs and other special drugs), hemodialysis and other special treatment of patients with chronic diseases need to provide medical services, patients with stable chronic diseasesHow longis long-term medication? : acute illness may be a week, the general routine can be said to be a month, there is also the explanation is six weeks, basically more than six weeks on the more definite is long-term medicationofficial term: Long prescriptions, known as "long-term prescriptions for chronic diseases," refer to prescriptions for chronically ill patients who have signed up to a family doctor, have a clear diagnosis, are stable, and require long-term medications for more than 2 weeks or morelength of time: can prescribe drugs for up to 12 weeks at a timeother instructions: inspection near, remote guidance, drug guidance, knowledge popularization, strengthen compliance, increase inspection and guidance, the implementation of bad drug criticism until accountabilityFengyun brief review: business owners --- sales team --- learning documents--- marketing department to follow up --- follow-up clinical / outpatient --- chain, first start for the strong, then drink soupA clear timetable of Jinan-based medicine 9.8.6, in accordance with the requirements of the comprehensive pilot program of the basic drug system in Shandong Province (Lu Wei Pharmaceutical S(2020) No2), formulated the "Jinan City implementation of the national basic drug system comprehensive pilot implementation program."However, Shandong Province this document did not findmain content: adhere to the basic drugs-led "1 plus X" (1 for the national list of essential drugs, X for non-essential drugs) drug use model 1, full coverage: by the end of 2020, the city's primary medical institutions (including public and non-public primary medical institutions) to implement the basic drug system coverage rate of 100%, non-public primary medical institutions, public health and basic medical services, through the purchase of services to support the implementation of the basic drug system 2, base drug 3.4.5.6: third, second and basic medical institutions basic drug regulations and the proportion of the use of the amount of the provincial standards of 30%, 40%, 50% and 30%, 40%, 60% State Bureau issued: gradually realize the government-run primary health care institutions, secondary public hospitals, tertiary public hospitals, the proportion of basic drug equipment in principle is not less than 90%, 80%, 60%, and promote medical institutions at all levels to form a basic drugs-led "1 plus X" ("1" for the national list of essential drugs, "X" as non-essential drugs, by the local basis for determination) drug use model, optimization and drug standardstructure doubt 1: the State Bureau requirements are the number of varieties (9.8.6), Jinan here is written in the basic drug regulation s3.4.5, this situation is almost impossible, the only understanding is here to ignore, should be the number of drug varieties 2: The country only asks for quantity, does not require the amount, 30% of the quantity to match 30% of the amount, 40% of the quantity to match 40% of the amount, 50% of the quantity to match 60% of the amount this dean not only have to manage, but also to calculate the math problem, the price of basic drugs are generally not high, three A hospital requires 30% of the quantity to match 30% of the amount, that new drug how to do? What do I do with cancer medication? How do China talk about high-priced products? 3, 3-5 years transition: on the basis of 2019 to increase 5-10% per year, through 3-5 years, the final realization of primary health care institutions, secondary and tertiary general hospitals equipped with the use of essential drugs in principle, the number of basic drugs in principle not less than 90%, 80%, 60% of the standard three-year --- 2020-2022, five years is 2020-2024, does that mean that the national essential drug system 9.8.6 and a three-to-five-year buffer period other information is routine information, priority use of basic drugs, shortage of drug system and so on, the core or the use of this basic drug Fengyun brief review: 1, kick variety: 3-5 years time, is to give the hospital gradually digest the number of products and structure of a time, if combined with DRG, then, a large number of varieties will kick out of the hospital kickout of the hospital variety is to consider, which products will kick out of the hospital? Which products won't kick out of the hospital? Who do you want to ask? --- pharmacy department, the director of the general, the head of the medical insurance bureau, the director of the department and so on 2, the grass-roots non-health insurance waste: the base medicine accounted for more than 80%, the grass-roots can use low-cost non-medical insurance products will die light 3, grass-roots no space for waste: the number of products other than the base medicine is very small, especially according to the same general name, large products grass-roots use is not available, the national pick spent points, the remaining places are few, tragic 4, the country has a certain space of fire: there are good reasons to do development, there is a little cost and policy support, small partners are you ready? 5, test field: Jinan this is not to give the best piece of test field, wear a good vest, comb a big back, Moss wax ingons are done, brand to do References: 1, domestic and foreign long prescription services comparative study of health economics research In April 2019 Volume 36, Issue 4, General Issue 384.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.